Physician profile
Phuc V Le
NPI 1235323775
$1,661.87
in general payments reported to CMS, 2019-2025
16 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.95 · 2020: $66.25 · 2021: $141 · 2022: $182 · 2023: $356 · 2024: $273 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $472.80 | 2023-2025 | Rocklatan, Dailies Total1 |
| Horizon Therapeutics Plc | $262.63 | 2021-2023 | Tepezza |
| Astellas Pharma US INC | $249.16 | 2023-2025 | Izervay |
| Amgen INC. | $194.70 | 2024-2025 | Tepezza |
| Allergan, INC. | $91.71 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $72.62 | 2019-2021 | |
| Coopervision INC. | $58.27 | 2022 | |
| Dompe US, INC. | $53.01 | 2021-2024 | Oxervate |
| Bausch & Lomb Americas INC. | $48.21 | 2022-2025 | Scoutpro Osmolarity System |
| Sun Pharmaceutical Industries INC. | $34.48 | 2020-2022 | |
| Apellis Pharmaceuticals, INC. | $27.24 | 2023 | Syfovre |
| Genentech USA, INC. | $23.86 | 2023 | Vabysmo |
| Rxsight INC | $19.68 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $19.44 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phuc Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.